SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-18-005544
Filing Date
2018-03-14
Accepted
2018-03-14 08:04:24
Documents
72
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ntla-10k_20171231.htm 10-K 3062584
2 EX-21.1 ntla-ex211_373.htm EX-21.1 3520
3 EX-23.1 ntla-ex231_9.htm EX-23.1 3770
4 EX-31.1 ntla-ex311_8.htm EX-31.1 9347
5 EX-31.2 ntla-ex312_7.htm EX-31.2 8728
6 EX-32.1 ntla-ex321_6.htm EX-32.1 7356
7 GRAPHIC g201803132345292496403.jpg GRAPHIC 33729
8 GRAPHIC g201803132345449456404.jpg GRAPHIC 32752
9 GRAPHIC g201803132345453476405.jpg GRAPHIC 33079
  Complete submission text file 0001564590-18-005544.txt   8649277

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT ntla-20171231.xml EX-101.INS 1705609
11 XBRL TAXONOMY EXTENSION SCHEMA ntla-20171231.xsd EX-101.SCH 50725
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ntla-20171231_cal.xml EX-101.CAL 46030
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ntla-20171231_def.xml EX-101.DEF 156963
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE ntla-20171231_lab.xml EX-101.LAB 391186
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ntla-20171231_pre.xml EX-101.PRE 308831
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37766 | Film No.: 18688352
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences